LANDA Embryo Freezing Technique.
Freezing
Use of the LANDA Embryo Freezing Technique to Validate Frozen Embryo Transfer Success Rates
1 other identifier
observational
20
1 country
1
Brief Summary
The aim of this study is to track the outcome from the patients who had embryo cryopreservation as part of their Advanced Reproductive Technology (ART) treatment at West Coast Fertility Centers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 5, 2011
CompletedFirst Posted
Study publicly available on registry
January 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedSeptember 8, 2011
September 1, 2011
1.1 years
January 5, 2011
September 6, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Freeze/Thawed survival rates
* Freeze / thaw survival rates * Blastocyst formation rates * Pregnancy rate.
When embryos thawed initiate
Eligibility Criteria
Infertility patients
You may qualify if:
- Infertile women whose physician has recommended IVF and who agree to cryopreserve surplus embryos.
- Cancer patients who wish to preserve their fertility prior to cancer treatments.
- Recipients who wish to use frozen donor embryos.
- A male partner whose semen analysis meets the clinic criteria for ICSI. Use of donor sperm is also acceptable.
- Be willing and able to comply with the protocol for the duration of the study.
- Have voluntarily provided written informed consent under WIRB.
You may not qualify if:
- A patient may NOT be entered into the study if she presents with ANY of the following criteria:
- Clinically significant systemic disease.
- Known endometriosis Grade III - IV (ASRM classification).
- Any previous cycle indicating a low response to gonadotropin stimulation (defined as retrieval of \< 10 eggs at retrieval)
- Three or more previous ART cycles without a clinical pregnancy
- Abnormal, undiagnosed, gynecological bleeding.
- Previous ovarian surgery
- Known allergy or hypersensitivity to recombinant gonadotropin preparations or any other study-related medications.
- Verifiable substance abuse.
- Simultaneous participation in another study protocol.
- Current smoker.
- An extrauterine pregnancy within the last 3 months before OCP treatment commences.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West Coast Fertility Centers
Fountain Valley, California, 92708, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David G. Diaz, M.D.
West Coast Fertility Centers
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director
Study Record Dates
First Submitted
January 5, 2011
First Posted
January 6, 2011
Study Start
December 1, 2010
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
September 8, 2011
Record last verified: 2011-09